We bridge the gap between international innovation and the Iraqi market, maintaining long-term partnerships with leading pharmaceutical manufacturers from Europe, the UK, India, and the Middle East.
Editable directory — partner profiles, therapeutic areas, and relationship types are managed from the WordPress dashboard.
Integrated global pharmaceutical company with presence in 60+ countries and US FDA-approved facilities. Our partnership brings world-class oncology and chronic-care portfolios to Iraq.
Historic Italian pharmaceutical company specializing in high-quality medicines and food supplements. EU GMP certified, with continuous R&D in gynecological, pediatric, and gastrointestinal therapies.
Leading Spanish pharmaceutical company renowned for quality and an extensive range of therapeutic solutions, with EU GMP manufacturing and a focus on affordable quality.
Innovators in heme-iron supplementation, providing solutions for iron deficiency with a clinical-efficacy focus and global market presence.
UK-based pharmaceutical company delivering high-quality medicines developed in strict compliance with UK MHRA and international guidelines, focused on niche therapeutic areas.
Leading manufacturer known for high-quality formulations and rapid international growth. EU GMP, US FDA, and ISO certified, with a broad therapeutic range and advanced manufacturing technology.
Excellence in contract research and manufacturing services with US FDA / EU GMP compliance, specializing in sterile injectables and complex formulations.
Committed to healthcare worldwide with a diverse portfolio of effective and safe pharmaceutical products and global reach.
A pioneer in softgel technology offering nutraceuticals and pharmaceutical formulations with enhanced bioavailability. EU GMP, US FDA, and ISO certified.
Dedicated to fighting infectious diseases through high-quality antibiotic formulations for critical-care treatment. WHO GMP and ISO certified.
Leading regional manufacturer dedicated to producing high-quality medicines that meet international standards, with a broad product portfolio.
Known for excellence in formulation development, an advanced R&D center, and a strong commitment to accessible healthcare with a chronic-disease focus.
A trusted name in the pharmaceutical industry, delivering reliable and effective treatments for decades with high-volume production capability.
International B2B pharmaceutical company headquartered in Malta, connecting a broad licensing portfolio with the Iraqi market through Al Sumo.
Turkish pharmaceutical company partnering with Al Sumo through a regional partnership model serving the Iraqi market.
Certification and exclusivity statements reflect the approved 2026 Company Profile and remain editable pending periodic Al Sumo review. Unverified claims are not published.
Full-service national distribution with brand promotion, forecast commitments, and agreed marketing investment.
Portfolio licensing and private-label structures leveraging our commercial platform and brand-building field force.
Connections to certified manufacturing capacity, coordinated through our regional group companies.
Local representation supporting your marketing authorization holder structure, pharmacovigilance, and regulatory duties.
Shared commercial execution combining your brand assets with our national field force.
Long-term ventures for regional expansion and portfolio acquisition across the group footprint.
